We are live on ! Find out more
PHAR

Pharming Group
PHAR

4 hedge funds and large institutions have $249K invested in Pharming Group in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.03% less ownership

Funds ownership: 0.03% → 0% (-0.03%)

33% less funds holding

Funds holding: 6 → 4 (-2)

89% less capital invested

Capital invested by funds: $2.17M → $249K (-$1.92M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$50.5K

Top Sellers

Rank Fund Capital Flow
1
JAM
JW Asset Management
Florida
-$1.91M
2
UBS Group
UBS Group
Switzerland
-$12.8K
3
TRCT
Tower Research Capital (TRC)
New York
-$1K

PHAR Hedge Fund Activity: Q3 2021 in Review

4 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q3 2021, worth a combined $249K — down 89% from $2.17M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHAR and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jane Street, adding an estimated $50.5K. The largest seller was JW Asset Management, exiting entirely with an estimated $1.91M sold.

  • 4 institutional investors held Pharming Group (PHAR) as of Q3 2021, down from 6 in Q2 2021.
  • Funds reported $249K of Pharming Group stock for Q3 2021, down 89% quarter-over-quarter.
  • 0 funds opened new Pharming Group positions in Q3 2021 and 2 closed out, a net change of -2 holders.
  • The largest Pharming Group buyer in Q3 2021 was Jane Street, an estimated $50.5K added.
  • The largest Pharming Group seller in Q3 2021 was JW Asset Management, an estimated $1.91M sold.

Based on aggregated 13F filings for Q3 2021.